Zacks Investment Research on MSN
Hims & Hers expands DTC platform to broaden access to personal care
Hims & Hers Health, Inc. HIMS has built its business around a digital, direct-to-consumer (DTC) platform that reimagines how ...
Few people consult a doctor before attempting weight loss. Hims offers virtual weight loss support for men, including consultations and prescriptions. Hims provides GLP-1 injections, meal replacements ...
In late March 2026, Hims & Hers Health, Inc. announced a renewed collaboration with Novo Nordisk to offer a broad range of FDA-approved GLP-1 medications, including Wegovy injections and the only ...
HIMS to offer treatment options for perimenopause and menopause via its platform ・Rising U.S. demand for hormone therapy strains supplies of estrogen patches. ・BofA raises HIMS price target but ...
Hims is a telehealth company offering discreet virtual consultations and prescription delivery for men's health concerns. Hims' hair loss program uses FDA-approved treatments like finasteride and ...
Telehealth investors weigh Amazon’s new anti-obesity drug push against this platform’s recent rapid growth, today, April 21, 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results